Provided by Tiger Fintech (Singapore) Pte. Ltd.

HANSOH PHARMA

36.060
-0.200-0.55%
Volume:3.41M
Turnover:123.73M
Market Cap:214.45B
PE:44.82
High:36.780
Open:35.600
Low:35.600
Close:36.260
Loading ...

BRIEF-Hansoh Pharmaceutical Says Drug Registration Approval Of Fourth Indication Of Aumolertinib Mesilate Tablets Granted By NMPA

Reuters
·
09 May

Hansoh Pharma Gets Breakthrough Therapy Deisgnation for Ovarian, Fallopian Tube Cancer Drug

MT Newswires Live
·
02 May

Hansoh Pharmaceutical Group Announces Breakthrough-Therapy Designation for B7-H4-Targeted ADC HS-20089 in China

Reuters
·
01 May

BRIEF-Hansoh Pharmaceutical Says NMPA Granted Breakthrough-Therapy-Designated Drug For HS-20089

Reuters
·
01 May

Hansoh Pharmaceutical Group Co. Ltd. Publishes 2024 Annual Report

Reuters
·
28 Apr

Hansoh Pharmaceutical Group Co. Ltd. Releases Environmental, Social and Governance Report

Reuters
·
28 Apr

Hansoh Pharmaceutical Gets China Nod to Register Vulvovaginal Candidiasis Drug

MT Newswires Live
·
28 Apr

BRIEF-Hansoh Pharmaceutical Receives Drug Registration Approval Of Hengmeida- (Ibrexafungerp Tablets)

Reuters
·
25 Apr

Hansoh Pharma's HS-20093 Drug Gets Another Breakthrough Therapy Designation in China

MT Newswires Live
·
18 Apr

BRIEF-Hansoh Pharmaceutical's Targeted Antibody Drug Conjugate Gets NMPA Breakthrough-Therapy-Designated-Drug

Reuters
·
17 Apr

Hansoh Pharma Gets Clinical Trial Nod in China for Cancer Drug

MT Newswires Live
·
16 Apr

BRIEF-Hansoh Pharmaceutical Says Clinical Trial Approval For HS-10529 Tablets Issued By NMPA

Reuters
·
15 Apr

Hansoh Pharmaceutical Gets China Nod for Trial of Two Tumor Drugs

MT Newswires Live
·
08 Apr

BRIEF-Hansoh Pharmaceutical Gains Clinical Trial Approval For HS-20108

Reuters
·
07 Apr

Greater China Stocks Slip; Taiwan Sees Largest Decline

Dow Jones
·
31 Mar

Nomura Adjusts Hansoh Pharmaceutical Group's Price Target to HK$19.86 From HK$18.36, Keeps at Neutral

MT Newswires Live
·
24 Mar

Hansoh Pharmaceutical's 2024 Profit Jumps 33%

MT Newswires Live
·
24 Mar

BRIEF-Hansoh Pharmaceutical Posts FY Revenue Of RMB 12,261 Million

Reuters
·
21 Mar

BRIEF-Hansoh Pharmaceutical Recommends Final Dividend Of HK$13.53 Cents Per Share

Reuters
·
21 Mar

Hansoh Pharmaceutical Gets Registration Go-Ahead for Third Indication of Cancer Drug

MT Newswires Live
·
11 Mar